JBS N.V. Class A Common Shares vs UBS Group AG Registered Ordinary Shares — how do they compare? JBS N.V. Class A Common Shares trades at $13 (market cap $13.86B), while UBS Group AG Registered Ordinary Shares trades at $47.42 (market cap $147.14B). The key difference: UBS Group AG Registered Ordinary Shares is far larger — about 10.6× JBS N.V. Class A Common Shares's market cap, and JBS N.V. Class A Common Shares pays the higher dividend (10.38%). Which is the better fit depends on your goals — on Pluang, investors hold JBS N.V. Class A Common Shares for 0 Days and UBS Group AG Registered Ordinary Shares for 3 Days on average.
| JBS | UBS | |
|---|---|---|
Market Cap | $13.86B | $147.14B |
Volume | 4,980,049 | 1,589,541 |
Sector | Consumer Staples | Financials |
52-Week High | $18.42 | $55.72 |
52-Week Low | $10.86 | $36.41 |
Typical Hold Time | 0 Days | 3 Days |
Enterprise Value | $34.83B | $315.77B |
Dividend Yield | 10.38% | 2.3% |
Signals from Pluang's Aura AI — not financial advice
JBS trades at $12.93, up 0.54% today, with a neutral technical signal and strong analyst buy consensus. The stock shows attractive valuation with a P/E of 12.08 and P/S of 0.47, though recent quarterly EPS misses and a declining profit margin to 1.22% in 2026 highlight earnings pressure. Recent news includes a proposal to acquire full control of Pilgrim's Pride and a joint venture in Southeast Asia, indicating strategic expansion.
The outlook is mixed: analyst targets suggest ~40% upside to $18.17, but risks include execution on acquisitions, margin compression, and volatile beef markets. Cash flow turned positive in 2026 projections, supporting growth initiatives, yet debt levels and competitive pressures warrant caution for investors seeking stability.
UBS trades at $47.85, showing minimal daily movement with a 0.06% gain. The technical picture is bearish with mixed earnings performance - beating estimates in Q1 2026 but missing in Q4 2025 and Q2 2026. Analyst sentiment leans positive with 55% buy ratings, though the consensus price target of $23.57 sits well below current levels. Recent news highlights UBS's strategic focus on US expansion and ongoing integration challenges.
The outlook remains cautious given the bearish technical signals and valuation concerns. Investment opportunity exists in the company's improving profitability and revenue growth trajectory, but risks include integration challenges from recent acquisitions and exposure to European debt market volatility. The significant gap between current price and analyst targets warrants careful consideration.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
JBS N.V. is a protein-processing company producing beef, pork, poultry, lamb, fish, and plant-based products, headquartered in São Paulo and Amsterdam. It operates more than 250 production facilities across over 16 countries under brands including Friboi, Seara, Swift, and Pilgrim's, and is the majority shareholder of Pilgrim's Pride Corporation.
Read more on JBS →UBS is a global financial services company focused on wealth management, investment banking, and asset management. It serves private, corporate, and institutional clients.
Read more on UBS →